首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Design, synthesis and evaluation of a series of acyclic fleximer nucleoside analogues with anti-coronavirus activity
【24h】

Design, synthesis and evaluation of a series of acyclic fleximer nucleoside analogues with anti-coronavirus activity

机译:设计,合成和评估一系列具有抗冠状病毒活性的无环fleximer核苷类似物

获取原文
获取原文并翻译 | 示例
           

摘要

A series of doubly flexible nucleoside analogues were designed based on the acyclic sugar scaffold of acyclovir and the flex-base moiety found in the fleximers. The target compounds were evaluated for their antiviral potential and found to inhibit several coronaviruses. Significantly, compound 2 displayed selective antiviral activity (CC50 >3x EC50) towards human coronavirus (HCoV)-NL63 and Middle East respiratory syndrome-coronavirus, but not severe acute respiratory syndrome-coronavirus. In the case of HCoV-NL63 the activity was highly promising with an EC50 <10 mu M and a CC50 >100 mu M. As such, these doubly flexible nucleoside analogues are viewed as a novel new class of drug candidates with potential for potent inhibition of coronaviruses. (C) 2015 Elsevier Ltd. All rights reserved.
机译:基于无环鸟苷的无环糖支架和在fleximers中发现的flex-base部分,设计了一系列双柔性核苷类似物。评价目标化合物的抗病毒潜力,发现它们可以抑制几种冠状病毒。值得注意的是,化合物2对人冠状病毒(HCoV)-NL63和中东呼吸综合征-冠状病毒显示出选择性的抗病毒活性(CC50> 3x EC50),但对严重的急性呼吸综合征-冠状病毒没有显示出抗病毒活性。在HCoV-NL63的情况下,其活性极有希望,EC50 <10μM,CC50> 100μM。因此,这些双柔韧性核苷类似物被视为具有潜在抑制潜力的新型新型药物候选物。冠状病毒。 (C)2015 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号